Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
27
TGA:27
Drug Approvals
HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial (407179)
- Product Name
- HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial
- Approval Date
- Jul 30, 2024
TGA
SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial (386895)
- Product Name
- SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial
- Approval Date
- Mar 27, 2023
TGA
SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet blister pack (392350)
- Product Name
- SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet blister pack
- Approval Date
- Mar 27, 2023
TGA
Cellular Therapies - T Cells - Axicabtagene ciloleucel, cryopreserved - T - Yescarta - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (400895)
- Product Name
- T Cells - Axicabtagene ciloleucel, cryopreserved - T - Yescarta
- Approval Date
- Dec 12, 2022
TGA
Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (396794)
- Product Name
- T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus
- Approval Date
- Sep 30, 2022
TGA
TRODELVY sacituzumab govitecan 180 mg powder for injection vial (353081)
- Product Name
- TRODELVY sacituzumab govitecan 180 mg powder for injection vial
- Approval Date
- Sep 6, 2021
TGA
BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets blister pack (365510)
- Product Name
- BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets blister pack
- Approval Date
- Aug 2, 2021
TGA
Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (371431)
- Product Name
- T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus
- Approval Date
- Jul 21, 2021
TGA
VEKLURY remdesivir 100 mg powder for injection vial (338419)
- Product Name
- VEKLURY remdesivir 100 mg powder for injection vial
- Approval Date
- Jul 10, 2020
TGA
BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets bottle (291923)
- Product Name
- BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets bottle
- Approval Date
- Jul 12, 2018
TGA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)No trials found
News
No news found